Testing a device to remove lung blood clots
Part of Lungs & breathing clinical trials.
This trial tests a new device (the Akura Thrombectomy System) that removes blood clots from the lungs in people with a sudden, severe pulmonary embolism. It aims to see if the device is safe and effective at improving blood flow and heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old.
- You have had symptoms of a pulmonary embolism (like sudden shortness of breath or chest pain) for 14 days or less.
- A CT scan shows a clot in a main artery of your lung and that the right side of your heart is enlarged or strained.
- Your blood pressure is stable (top number at least 90 mmHg), and your heart rate is under 130 beats per minute.
- You are healthy enough for a procedure and have no major bleeding risks, severe kidney disease, or other serious conditions listed in the trial's exclusion criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.
This trial tests a new system to remove blood clots from the lungs in people with acute pulmonary embolism (a sudden blockage in a lung artery). It may help those who are stable enough for a catheter-based procedure but still have significant strain on the heart.
This trial tests the Vibrato Aspiration System, a device that suctions blood clots from the lungs in people with a recent pulmonary embolism (PE). It aims to see if the procedure is safe and works well for removing clots.
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
This study tests a device that suctions blood clots from the lungs in people with a moderate-risk pulmonary embolism. The goal is to see if it is safe and effective at removing clots and improving blood flow.
This study compares two ways to treat a large blood clot in the lungs that is causing life-threatening symptoms. One method uses a device to remove the clot, the other uses medicine to dissolve it.
Hear when a new Pulmonary Embolism Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.